Med spa rewards programs: what Alle, Aspire, and the rest actually pay you

Four of the five major manufacturer loyalty programs, Allergan, Merz, Evolus, and Revance, do not send your practice a rebate check. They lower your per-unit invoice price based on your purchasing volume. The discount is embedded in what you pay your distributor. There is no separate payment, no quarterly wire, nothing to book. Galderma is the exception. ASPIRE practice agreements include actual quarterly rebate checks, and most practices book them wrong. If you credit that check to "other income" rather than reducing your COGS, your injectable gross margin looks worse than it is. You have no accurate number to take into your next rep conversation.

How manufacturer rewards programs work on the practice side

Every major aesthetic manufacturer runs two programs in parallel: one for patients, one for practices. The patient side (Alle points, Aspire savings, Evolus discounts) is designed to drive return visits and keep patients loyal to a particular product. The practice side is a purchasing volume incentive. The more you spend with a single manufacturer, the lower your per-unit cost on their products.

The mechanism varies, and the distinction matters for your books. When the value comes as an embedded invoice discount, it reduces your COGS at the moment of purchase. No additional accounting entry needed. You simply paid less. When the value comes as a separate check, as with Galderma, it is a cash receipt that needs to be applied against the product cost it relates to under ASC 705-20, the accounting standard that governs vendor rebates. Most practices do not handle this correctly.

The five programs: practice-side mechanics

Alle — Allergan Partner Privileges (APP)

Allergan's practice-facing program is called Allergan Partner Privileges, separate from the Alle patient loyalty app that patients interact with at checkout. APP is a tiered pricing structure. Your annual Allergan spend across Botox Cosmetic, Juvederm, Kybella, SkinMedica, CoolSculpting, and Skinvive determines which tier you sit in. Higher tiers produce lower per-unit invoice costs on all Allergan products. There is no rebate check. The discount shows up in what you pay your distributor on each order.

The most common reconciliation failure: Allergan tracks your purchases through your distributor account feed. If you buy from multiple distributors or under multiple account numbers that are not consolidated into a single practice profile, your purchases split across profiles. You appear to be a lower-volume buyer than you are, which keeps you in a lower tier. We cover how to catch these distributor-side gaps in detail here. The short version: log into Allergan One monthly and compare their purchase record against your actual invoices. Any gap is costing you tier status.

When patients redeem Alle points at your practice, Allergan ships product to fulfill the redemption. You administer it and charge a provider fee for your time. That product has fair market value. A $600 Juvederm syringe received at no cash cost and administered on a patient is $600 in taxable inventory at receipt, then $600 in COGS when used. Most practices record neither line. The correct treatment: debit inventory at FMV when the product arrives, credit income. Debit COGS, credit inventory when administered. Confirm with your CPA. Allergan does not typically issue a 1099 for this product, which does not mean it is not taxable.

ASPIRE — Galderma

Galderma's practice-side program runs through purchasing agreements negotiated separately with your Galderma rep. ASPIRE is primarily the patient loyalty program. The practice benefits come from the wholesale purchasing agreement, which carries its own tier structure tied to annual Galderma spend on Dysport, Restylane, Sculptra, and Cetaphil.

Galderma is the only major manufacturer that pays an actual quarterly rebate check, issued 30 to 45 days after quarter end. At the highest tier, which requires directing roughly 96% of your aesthetic purchasing toward Galderma products, the rebate reaches 6% of qualifying quarterly spend. Practices that grow their Galderma purchasing year over year can unlock an additional growth rebate, bringing the effective rate up to 8%. On $30,000 in quarterly Galderma purchases at the standard top tier, that is $1,800 per quarter, $7,200 per year.

The correct accounting treatment under ASC 705-20: that $1,800 check is a reduction in the cost of the Dysport and Restylane it relates to. Debit cash $1,800, credit COGS $1,800. Your injectable gross margin for that quarter goes up by $1,800. Tracking COGS by vendor is how you see whether this math is working in your favor. Booking the rebate as "other income" is the common error. It makes your COGS look higher than it is and obscures your true margin on Galderma-sourced injectables.

Galderma agreements can include clawback provisions. If you commit to a volume tier and fall short in a quarter, Galderma may recapture a portion of the discount. Read your signed agreement before assuming there is no downside to a slow quarter.

Xperience+ — Merz Aesthetics

Merz covers Xeomin, Radiesse, Belotero Balance, Ultherapy, and Neocutis skincare through Xperience+. The structure is tiered invoice pricing plus quarterly promotional product credits. No rebate check under the standard program. Value is embedded in per-unit pricing.

Merz runs promotional bonuses on top of the base tier: buy a volume of Xeomin within a promotional window and receive free vials. Those free vials have fair market value. Same accounting issue as Allergan's redemption product. Inventory received at no cash cost has a FMV that should be recognized as income at receipt and as COGS when administered. Most practices record neither. Practice portal is at portal.merzaesthetics.com. Support line: 1-844-469-6379 if your purchase history does not match your invoices.

Evolus

Evolus markets Jeuveau as a lower-cost neurotoxin and has built their practice-side program to match: tiered pricing based on annual Jeuveau vial purchases. One product, one tier structure, less complexity than the Big 3. No rebate check. Lower per-vial invoice cost at each tier.

Club Evolus, launched November 2024, is a patient-facing subscription ($49 per month for 20 units of Jeuveau every 90 days). It affects your scheduling workflow and front desk. Patients arrive with a subscription entitlement to verify. It does not change the practice-side purchasing tier mechanics.

EDGE — Revance

Revance's provider program covers DAXXIFY and the Teoxane RHA filler collection. Per Revance's public page, EDGE is built on transparent volume pricing: higher spend, lower per-unit cost. No enrollment fees. Tier thresholds are not publicly disclosed and are shared through your Revance rep. Revance went through significant restructuring in 2024, selling their pharmaceutical division to Crown Laboratories. Their aesthetics business, including DAXXIFY and EDGE, continues under Revance Aesthetics.

Program comparison: what you actually receive

How to audit whether your purchases are being credited

Every program tracks your spend through their portal, pulling from your distributor account feed. You have limited visibility into whether their system is counting your purchases correctly. These five steps catch the most common errors:

1. Pull every distributor invoice from the past 12 months and sort by manufacturer. Calculate your total spend per manufacturer from your own records.
2. Log into each manufacturer portal (Allergan One, ASPIRE Practice portal, MyMerz Solutions, MyEvolus) and pull their record of your purchases for the same 12-month period.
3. Compare totals line by line. Any invoice in your records that does not appear in their portal is missing from your tier calculation and may be holding you below the tier you have earned.
4. For promotional bonuses tied to a specific quarter, match your invoice date in their system, not your order date. A purchase ordered December 30 that ships and invoices January 2 falls outside a December promotion window in their system.
5. If their portal shows lower spend than your invoices, contact your distributor rep first. The most common cause is a broken account linkage. If they cannot resolve it, escalate to the manufacturer's practice support line.

The root cause of most undercounting is distributor account fragmentation. If you buy from Henry Schein under one account number and from McKesson under a second, and both do not link to the same practice profile in the manufacturer's system, your spend splits. You look like a smaller buyer than you are. Confirm with each distributor that all your account numbers resolve to a single practice profile in each manufacturer's portal.

What Galderma's rebate check actually does to your margin

The $7,200 annual difference is not a tax issue. It is a reporting issue. When your injectable COGS looks $7,200 higher than it actually is, your gross margin on Galderma products looks worse than it is. That affects how you evaluate whether Dysport is more or less profitable than Botox, whether a price increase is warranted, and whether the Galderma volume commitment is worth the exclusivity it requires. Wrong booking produces wrong conclusions.